Abstract
Primary intracranial lymphomas (Weller et al. in Neuro Oncol 14(12):1481–1484, 2012) are an emerging disease and an isolated localization in the pituitary gland i.e. primary pituitary lymphoma (PPL) represents a rare condition. We present an update of the most recent evidence for PPL through a systematic review of the literature. A systematic literature review was conducted using PubMed database up to October 2015. The population was defined as immunocompetent patients with a pathologically confirmed diagnosis of PPL. Patients’ characteristics, clinical presentation, radiological features, pathology reports, adjuvant treatment and follow-up data were analyzed. We reported one case of PPL and included our data in this analysis. A total of 33 cases of PPL were identified, including ours. A slight not significant female prevalence was evident, with a mean age of 59 years at diagnosis. Visual troubles and headaches were the most common presenting symptoms. About 80 % of patients presented a cranial nerve (CN) deficit. The most frequently involved were the II and III CN. Anterior hypopituitarism was present in 70 % of cases and a diabetes insipidus in 36 % of cases. PPL was rarely limited to the sella and most often extended to the suprasellar and parasellar space. 70 % of cases underwent resection, 21 % a biopsy. A B-cell lymphoma was isolated in 82 % of cases, a T-cell lymphoma in 15 % and a NK/T cell lymphoma in one case. Overall mean survival rate was 14.4 months (95 % confidence interval 9.0–19.8 months) and there was no difference in terms of survival rates when patients were stratified according to the treatment they received. PPL is an emerging clinical entity. Literature data are too scarce to allow the definition of specific protocols of treatment and the management is based on the guidelines present for PCNSL. The role of surgery aiming at a complete resection of PPL should be reevaluated in wider studies including only this category of patients, to establish the real role of each therapeutic strategy.
Similar content being viewed by others
References
Clayton RN (1999) Sporadic pituitary tumours: from epidemiology to use of databases. Bailliere’s Best Pract Res Clin Endocrinol Metab 13(3):451–460
Famini P, Maya MM, Melmed S (2011) Pituitary magnetic resonance imaging for sellar and parasellar masses: 10-year experience in 2598 patients. J Clin Endocrinol Metab 96(6):1633–1641
Weller M, Martus P, Roth P, Thiel E, Korfel A, German PSG (2012) Surgery for primary CNS lymphoma? Challenging a paradigm. Neuro Oncol 14(12):1481–1484
Fine HA, Mayer RJ (1993) Primary central nervous system lymphoma. Ann Intern Med 119(11):1093–1104
Snider WD, Simpson DM, Aronyk KE, Nielsen SL (1983) Primary lymphoma of the nervous system associated with acquired immune-deficiency syndrome. N Engl J Med 308(1):45
Samaratunga H, Perry-Keene D, Apel RL (1997) Primary lymphoma of pituitary gland: a neoplasm of acquired malt? Endocr Pathol 8(4):335–341
Shaw JA, Strachan FM, Sawers HA, Bevan JS (1997) Non-Hodgkin lymphoma with panhypopituitarism, hyperprolactinaemia and sixth nerve palsy. J R Soc Med 90(5):274–275
Kuhn D, Buchfelder M, Brabletz T, Paulus W (1999) Intrasellar malignant lymphoma developing within pituitary adenoma. Acta Neuropathol (Berl) 97(3):311–316
Au WY, Kwong YL, Shek TW, Leung G, Ooi C (2000) Diffuse large-cell B-cell lymphoma in a pituitary adenoma: an unusual cause of pituitary apoplexy. Am J Hematol 63(4):231–232
Mathiasen RA, Jarrahy R, Cha ST, Kovacs K, Herman VS, Ginsberg E et al (2000) Pituitary lymphoma: a case report and literature review. Pituitary 2(4):283–287
Giustina A, Gola M, Doga M, Rosei EA (2001) Clinical review 136: primary lymphoma of the pituitary: an emerging clinical entity. J Clin Endocrinol Metab 86(10):4567–4575
Landman RE, Wardlaw SL, McConnell RJ, Khandji AG, Bruce JN, Freda PU (2001) Pituitary lymphoma presenting as fever of unknown origin. J Clin Endocrinol Metab 86(4):1470–1476
Kaufmann TJ, Lopes MB, Laws ER Jr, Lipper MH (2002) Primary sellar lymphoma: radiologic and pathologic findings in two patients. Am J Neuroradiol 23(3):364–367
Katz BJ, Jones RE, Digre KB, Warner JE, Moore KR (2003) Panhypopituitarism as an initial manifestation of primary central nervous system non-Hodgkin’s lymphoma. Endocr Pract 9(4):296–300
Lee JH, Lee HK, Choi CT, Huh J (2002) Mucosa-associated lymphoid tissue lymphoma of the pituitary gland: MR imaging features. Am J Neuroradiol 23(5):838–840
Huang YY, Lin SF, Dunn P, Wai YY, Hsueh C, Tsai JS (2005) Primary pituitary lymphoma presenting as hypophysitis. Endocr J 52(5):543–549
Liu JK, Sayama C, Chin SS, Couldwell WT (2007) Extranodal NK/T-cell lymphoma presenting as a pituitary mass. Case report and review of the literature. J Neurosurg 107(3):660–665
Rudnik A, Larysz D, Blamek S, Larysz P, Bierzynska-Macyszyn G, Wlaszczuk P et al (2007) Primary pituitary lymphoma. Folia Neuropathologica/Association of Polish Neuropathologists and Medical Research Centre. Pol Acad Sci 45(3):144–148
Chen SM, Chang CN, Wei KC, Jung SM, Chuang CC (2008) Sellar lymphoma mimicking sphenoid infection presenting with cavernous sinus syndrome. J Clin Neurosci 15(10):1148–1151
Kozakova D, Machalekova K, Brtko P, Szepe P, Vanuga P, Pura M (2008) Primary B-cell pituitary lymphoma of the Burkitt type: case report of the rare clinic entity with typical clinical presentation. Cas Lek Cesk 147(11):569–573
Romeike BF, Joellenbeck B, Stein H, Loddenkemper C, Hummel M, Firsching R et al (2008) Precursor T-lymphoblastic lymphoma within a recurrent pituitary adenoma. Acta Neurochir (Wien) 150(8):833–836
Moshkin O, Muller P, Scheithauer BW, Juco J, Horvath E, Patterson BJ et al (2009) Primary pituitary lymphoma: a histological, immunohistochemical, and ultrastructural study with literature review. Endocr Pathol 20(1):46–49
Quintero Wolfe S, Hood B, Barker J, Benveniste RJ (2009) Primary central nervous system lymphoma mimicking pituitary apoplexy: case report. Pituitary 12(1):76–79
Tamer G, Kartal I, Aral F (2009) Pituitary infiltration by non-Hodgkin’s lymphoma: a case report. J Med Case Rep 3:9293
Bayraktar S, Bassini W, Goodman M (2010) Primary pituitary lymphoma: idiopathic anasarca with relapse in bone marrow only. Acta Haematol 123(2):121–125
Hayasaka K, Koyama M, Yamashita T (2010) Primary pituitary lymphoma diagnosis by FDG-PET/CT. Clin Nucl Med 35(3):205
Martinez JH, Davila Martinez M, Mercado de Gorgola M, Montalvo LF, Tome JE (2011) The coexistence of an intrasellar adenoma, lymphocytic hypophysitis, and primary pituitary lymphoma in a patient with acromegaly. Case Rep Endocrinol 2011:941738
Anila KR, Nair RA, Koshy SM, Jacob PM (2012) Primary intravascular large B-cell lymphoma of pituitary. Indian J Pathol Microbiol 55(4):549–551
Carrasco CA, Rojas ZD, Chiorino R, Gonzalez G (2012) Primary pituitary lymphoma in immunocompetent patient: diagnostic problems and prolonged follow-up. Pituitary 15(1):93–96
Li Y, Zhang Y, Xu J, Chen N (2012) Primary pituitary lymphoma in an immunocompetent patient: a rare clinical entity. J Neurol 259(2):297–305
Papanastasiou L, Pappa T, Dasou A, Kyrodimou E, Kontogeorgos G, Samara C et al (2012) Case report: primary pituitary non-Hodgkin’s lymphoma developed following surgery and radiation of a pituitary macroadenoma. Hormones 11(4):488–494
Rainsbury P, Mitchell-Innes A, Clifton N, Khalil H (2012) Primary lymphoma of the pituitary gland: an unusual cause of hemianopia in an immunocompetent patient. JRSM Short Rep 3(8):55
Wiens AL, Hagen MC, Bonnin JM, Rizzo KA (2012) T-cell lymphoblastic lymphoma/leukemia presenting as a pituitary mass lesion: a case report and review of the literature. Neuropathology 32(6):668–674
Wilkie MD, Al-Mahfoudh R, Javadpour M (2012) A rare case of primary sellar lymphoma presenting a diagnostic challenge. Br J Neurosurg 26(5):782–783
Singh VP, Mahapatra AK, Dinde AK (1993) Sellar-suprasellar primary malignant lymphoma: case report. Indian J Cancer 30(2):88–91
Freda PU, Post KD (1999) Differential diagnosis of sellar masses. Endocrinol Metab Clin N Am 28(1):81–117
Eby NL, Grufferman S, Flannelly CM, Schold SC Jr, Vogel FS, Burger PC (1988) Increasing incidence of primary brain lymphoma in the US. Cancer 62(11):2461–2465
Popovic V, Damjanovic S, Micic D, Nesovic M, Djurovic M, Petakov M et al (1998) Increased incidence of neoplasia in patients with pituitary adenomas. The pituitary study group. Clin Endocrinol (Oxf) 49(4):441–445
O’Neal KD, Schwarz LA, Yu-Lee LY (1991) Prolactin receptor gene expression in lymphoid cells. Mol Cell Endocrinol 82(2–3):127–135
Messerer M, De Battista JC, Raverot G, Kassis S, Dubourg J, Lapras V et al (2011) Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal. Neurosurg Focus 30(4):E11
Bataille B, Delwail V, Menet E, Vandermarcq P, Ingrand P, Wager M et al (2000) Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 92(2):261–266
Bellinzona M, Roser F, Ostertag H, Gaab RM, Saini M (2005) Surgical removal of primary central nervous system lymphomas (PCNSL) presenting as space occupying lesions: a series of 33 cases. Eur J Surg Oncol 31(1):100–105
Lai R, Rosenblum MK, DeAngelis LM (2002) Primary CNS lymphoma: a whole-brain disease? Neurology 59(10):1557–1562
Korfel A, Thiel E, Martus P, Mohle R, Griesinger F, Rauch M et al (2015) Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma. Neurology 84(12):1242–1248
Thiel E, Korfel A, Martus P, Kanz L, Griesinger F, Rauch M et al (2010) High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncol 11(11):1036–1047
Morris PG, Correa DD, Yahalom J, Raizer JJ, Schiff D, Grant B et al (2013) Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. J Clin Oncol 31(31):3971–3979
Kumar R, Laack N, Pollock BE, Link M, O’Neill BP, Parney IF (2015) Stereotactic radiosurgery in the treatment of recurrent CNS lymphoma. World Neurosurg 84(2):390–397
Kenai H, Yamashita M, Nakamura T, Asano T, Momii Y, Nagatomi H (2006) Gamma Knife surgery for primary central nervous system lymphoma: usefulness as palliative local tumor control. J Neurosurg 105(Suppl):133–138
Hirono S, Iwadate Y, Higuchi Y, Serizawa T, Nagano O, Matsutani T et al (2015) Stereotactic radiosurgery in combination with up-front high-dose methotrexate as a first-line treatment for newly diagnosed primary central nervous system lymphoma. J Neuro Oncol 123(2):237–244
Kasenda B, Ferreri AJ, Marturano E, Forst D, Bromberg J, Ghesquieres H et al (2015) First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)—a systematic review and individual patient data meta-analysis. Ann Oncol 26(7):1305–1313
Gerstner ER, Carson KA, Grossman SA, Batchelor TT (2008) Long-term outcome in PCNSL patients treated with high-dose methotrexate and deferred radiation. Neurology 70(5):401–402
Yang SH, Lee KS, Kim IS, Hong JT, Sung JH, Son BC et al (2009) Long-term survival in primary CNS lymphoma treated by high-dose methotrexate monochemotherapy: role of STAT6 activation as prognostic determinant. J Neuro Oncol 92(1):65–71
Jahnke K, Thiel E, Martus P, Herrlinger U, Weller M, Fischer L et al (2006) Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors. J Neuro Oncol 80(2):159–165
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Additional information
A. Tarabay and G. Cossu have contributed equally to the conception of the work and analysis of data, drafting and revision and final approval of the version to be published.
Rights and permissions
About this article
Cite this article
Tarabay, A., Cossu, G., Berhouma, M. et al. Primary pituitary lymphoma: an update of the literature. J Neurooncol 130, 383–395 (2016). https://doi.org/10.1007/s11060-016-2249-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-016-2249-z